fda warns semaglutide MedWatch FDA warns about semaglutide overdoses,

Body aches and joint pain have been reported with tirzepatide use, but these affect muscles and joints, not the thyroid gland

Consult a qualified healthcare professional before starting any prescription treatment

Semaglutide mimics the GLP-1 hormone to: Slow food movement through your stomach, helping you feel fuller for longer Reduce hunger signals in your brains appetite centre Improve blood sugar control by enhancing insulin function The difference in outcomes comes down to dose

Glucagon-like peptide-1/glucagon receptor agonism associates with reduced metabolic adaptation and higher fat oxidation: a randomized trial